Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 19/20 | 0.52 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15498130 | 1.00 | FOLH1 (0.52) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL15498145 | 0.90 | FOLH1 (0.41) | FOLH1 | |
| SCHEMBL18161564 | 0.89 | TDP1 (0.39) | FOLH1 | |
| SCHEMBL15510866 | 0.89 | TDP1 (0.39) | FOLH1 | |
| SCHEMBL15510867 | 0.89 | TDP1 (0.39) | FOLH1 | |
| SCHEMBL18145414 | 0.89 | FOLH1 (0.61) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL22712960 | 0.89 | FOLH1 (0.61) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL18145412 | 0.89 | FOLH1 (0.61) | FOLH1RIMKLANAALAD2 | |
| SCHEMBL15495587 | 0.86 | TDP1 (0.37) | FOLH1 | |
| SCHEMBL14682796 | 0.84 | TDP1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200407331-A1 | UNIVERSAL BUILDING BLOCKS FOR RADIOLABELING | HELMHOLTZ-ZENTRUM DRESDEN - ROSSENDORF E.V. (DE) | 2020-12-31 | — | — | US | disclosed |
| EP-3694826-A1 | UNIVERSAL BUILDING BLOCKS FOR RADIOLABELING | Helmholtz-Zentrum Dresden - Rossendorf e.V. (DE) | 2020-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407331-A1 | UNIVERSAL BUILDING BLOCKS FOR RADIOLABELING | TYK2, KIT, FLT3 | FOLH1 342/4885RIMKLA 1207/4885NAALAD2 264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.